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Abstract
Background: Long cross clamp times have been associated with poor clinical outcomes, yet some patients require
extremely long ischemic times to repair complex surgical problems. The purpose of this study was to examine short
and mid-term survival and to identify risk factors for mortality and morbidity in patients with cross clamp times
greater than or equal to 300 min.
Methods: Review of our institution’s Society of Thoracic Surgeons database identified 202 patients who underwent
surgical procedures necessitating aortic cross clamp times 300 min or greater between 2001 and 2012. Short-term
(30-day) clinical outcomes were derived from this database and survival was assessed utilizing the Social Security
Death Index. Univariate and multivariate analyses were used to determine the relationship between independent
variables and mortality and postoperative outcomes.
Results: The average age of the patients was 69.5 ± 10.6 (mean ± standard deviation) years and the mean ejection fraction
was 52 ± 12 %. 70.3 % of patients were male. Mean cross clamp time was 346 ± 45 min, and total bypass time was 421 ±
70 min. Thirty-day mortality was 12.4 %. The incidence of bleeding and stroke were 6.4 % and 4.0 % respectively. Prolonged
ventilation occurred in 26.7 % of patients, and incidence of renal failure was 10.4 %. One, three, five, and seven year survival
of the patients who survived the first 30 days post-surgery was 91.9 %, 83.2 %, 75.6 % and 65.7 % respectively. Proportional
hazards analysis determined that the statistically significant hazard ratios for mid-term mortality for female gender, age, and
prolonged postoperative ventilation were 2.11, 1.04 and 2.72, respectively (p < 0.05 for each).
Conclusions: Cardiac procedures requiring extremely long ischemic times have significant early mortality and morbidity.
However, mid-term survival in the patients who survive is good. Decision-making regarding operability in complex cases
should allow for long ischemic times.
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Background
Clinical studies have shown that aortic cross-clamp (XCL)
time and cardiopulmonary bypass time (CPB) during car-
diac surgery are independent predictors of mortality and
morbidity in postoperative patients [1, 2, 4]. Increasing
XCL times are associated with low cardiac output, pro-
longed ventilation, renal compromise, and neurological
deficit immediately following surgery [1–5]. With the vari-
ous adverse effects associated with long XCL times, mid-
term survival after complex surgeries has historically had
a poor prognosis. A study by Al-Sarraf et al. showed that
in-hospital mortality was significantly higher for patients
with XCL times greater than 90 min than for patients with
XCL times >60 ≤ 90 min [1]. Furthermore, the in-hospital
mortality within the latter group was significantly higher
than that of patients with XCL times ≤ 60 min.
There are no large reports in the literature regarding the
effects of XCL times greater than 300 min and few studies
that examine mid-term survival as a function of XCL time.
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A large study by Doenst et al. examined data from 28,684
patients but excluded data from patients with XCL times
over 120 min [4]. A study by Nissinen et al. examined 30-
day mortality as a function of XCL time, but only included
data from 30 patients with XCL times greater than
300 min [2]. Therefore, our study retrospectively exam-
ined clinical outcomes in a cohort of patients undergoing




This study includes data collected from an analysis of our
institution’s prospectively collected Society of Thoracic
Surgeons (STS) database. All patients with primary cross
clamp times over 300 min within the last 14 years were
reviewed. Patients excluded included those who required a
second cross clamp, any patients that had a ventricular as-
sist device inserted and those with additional ischemic time
for further repair. A total of 202 patients were identified
who underwent complex surgical procedures necessitating
single aortic cross clamp time 300 min or greater between
2001 and 2012. 113 patients were seen from 2001–2006
and 89 patients from 2007–2012. Our practice operates
within a large, tertiary institution and saw approximately
900 patients per year until 2010 and 1,000 patients per year
thereafter.
Pre-, intra-, and postoperative variables were gathered
on all patients. Operative notes were obtained for data
regarding the type of surgery. Short-term (30-day) clinical
outcomes were derived from our STS database. Mid-term
survival data (<14 years) of patients who survived the ini-
tial surgery was derived from the Social Security Death
Index [23].
Cardiopulmonary bypass
All surgeries were performed using generalized, standard
anesthesia. Following a median sternotomy, a heparin
dose of 350 IU/kg was given to maintain an activated
clotting time of 400–600 s. Cannulation was accom-
plished as per the normal institutional protocol. A mem-
brane oxygenator and roller pump system was used
along with a heparin coated tubing set. 10,000 IU hep-
arin and 1,400 mL Hartmann’s solution was used to
prime the extracorporeal circuit. On average, the pa-
tients were cooled to 32 °C. Myocardial protection was
accomplished with antegrade and retrograde cold blood
cardioplegia in a 4:1 solution. Cardioplegia was delivered
every 15 min and titrated to maintain distal septal
temperature of less than 10° Celsius. A warm retrograde
shot was given before clamp removal. Surgeries were
performed with one aortic cross clamp. Both cardiotomy
suction and cell saver were used, with cell saver used
primarily for blood shed into the pericardium. Milrinone
and levophed were used in the majority of patients to
wean from bypass.
Statistical Analysis
Categorical data are expressed as percentages and quantita-
tive variables are reported as the mean ± standard deviation
(SD). The χ2 test and the Fisher’s Exact Test were used for
the univariate analyses of categorical data and the unpaired
t-test for was used for the univariate analysis of continuous
data. A Kaplan-Meier survival curve was constructed from
patient mortality data for those patients surviving more
than 30 days postoperatively. Two logistic regression ana-
lyses were performed, using the 30-day outcomes of either
mortality or complications as the dependent variables. For
these analyses, independent variables tested included pa-
tient age, gender, perfusion time, cross clamp time, surgery
type (whether or not the procedure included a coronary
artery bypass graft (CABG)), and era (surgery performed
from 2001–2006 vs. 2007–2012).
Univariate and multivariate analyses with respect to
complications included eight 30-day postoperative com-
plications. These complications are stroke, renal failure,
perioperative myocardial infarction (MI), deep sternal in-
fection, ventilation time > 48 h, atrial fibrillation, bleeding
requiring reoperation and pneumonia. Stroke was defined
as a confirmed neurological deficit of abrupt onset that
does not resolve in 24 h. Renal failure was defined as an
increase in creatinine 3.0 times over baseline, or as any
requirement for dialysis. Perioperative MI was defined as
new Q waves on ECG or troponin levels over 30. Deep
sternal infection was defined as all of the following: (i.)
wound opened with incision and drainage or any re-
exploration, (ii.) positive wound cultures and (iii.) treat-
ment with antibiotics beyond perioperative prophylaxis.
Ventilation time > 48 was defined as any prolonged post-
operative mechanical ventilation over 48 h. Finally, pneu-
monia was defined as the presence of lung infiltrate and
pathogenic sputum culture, and placement on antibiotics
for pneumonia.
A Cox proportional hazards analysis was performed,
using mid-term mortality (occurring more than 30 days
and < 14 years following the surgical procedure) as the
dependent variable. The independent variables used in-
cluded patient age, gender, perfusion time, cross clamp
time, surgery type, era, and ventilation time >48 h. Signifi-
cance was assessed at p < 0.05. IBM SPSS Statistics version
22.0 (Armonk, NY, USA) was used to perform the statistical
analyses.
Results
Preoperative clinical characteristics and patient demograph-
ics are summarized in Table 1. Patients ranged in age from
35 to 89 years. The majority of the patients were males,
and less than 5 % of the cases were emergent. Only 10.4 %
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of the patients were operated on within 21 days of myocar-
dial infarction. Over three-quarters of the patients were
New York Heart Association (NYHA) class III and IV
(75.3 %).
Table 2 presents operative data for the patient group. The
majority of patients (77.3 %) underwent valve repair or
replacement procedures with CABG. Mitral valve repair
involved 59.5 % of the surgeries, 72.4 % involved aortic
valve replacement and 16.4 % involved tricuspid repair.
There were two isolated mitral valves in patients with se-
vere mitral annular calcification. Additionally, 15.8 % of sur-
geries were reoperations. The isolated CABG procedures
were all revisions with severe adhesions and patent grafts.
Intraoperative and postoperative data are presented in
Table 3. The mean CPB and XCL times were both more
than five hours. The most frequent postoperative complica-
tions were: atrial fibrillation, prolonged ventilation >48 h,
renal failure, and pneumonia.
The results of univariate analyses with respect to patient
death are shown in Table 4. The mortalities are presented
as total mortalities (“all deaths”), mortalities within 30 days
(“operative deaths”), and mortalities after 30 days (mid-
term deaths). Female gender, and increased age, perfusion
time and cross clamp time, were significantly associated
with increased overall death. Perfusion time, cross clamp
time, era, ventilation > 48 h, total ventilation time, total
Intensive Care Unit (ICU) stay and length of hospital stay
were significantly associated with increased mid-term
death, while female gender and perfusion time were sig-
nificantly associated with operative deaths.
Univariate analyses with respect to complications other
than mortality are shown in Table 5. Increased perfusion
and cross clamp time were both associated with increased
30-day complications. Additionally, length of hospital stay,
total ICU stay and ventilation > 48 h were also significantly
related to increased complications.
Logistic regression analysis was performed using 30-
day mortality or 30-day complications as the dependent
variables (Table 6). Female gender was the only independ-
ent variable that was significantly predictive of mortality.
Table 1 Preoperative characteristics (n = 202)
Variable No. (%)
Patient Age (y)a 69.5 ± 10.6
Gender (males, %) 142 (70.3 %)
Preoperative status
Elective 138 (68.3 %)
Urgent 55 (27.2 %)
Emergent/salvage 9 (4.5 %)
Incidence
Reoperation 32 (15.8 %)
First operation
IABP - Preoperative 170 (84.2 %)
6 (3.0 %)
Smoker 91 (45.0 %)
Angina type
Unstable 15 (7.4 %)
Stable 65 (32.2 %)
Time from MI to surgery
1–7 days 10 (5.0 %)
8–21 days 11 (5.4 %)
> 21 days 43 (21.3 %)
NYHA class
≤ 2 41 (24.7 %)
3 and 4 125 (75.3 %)
Diabetes 64 (31.7 %)
Ejection fraction ≤50 % 77 (39.5 %)
Ejection fraction (%)a 52.0 ± 12.0
IABP intra-aortic balloon pump, MI myocardial infarction, NYHA New York
Heart Association
aMean ± SD
Table 2 Procedural characteristics and their distribution among
patients within the sample (n = 202)a
Variable No. (%)
Mitral
+ other1 3 (1.5 %)
+ tricuspid + other2 3 (1.5 %)
Isolated 2 (1.0 %)
Aortic
+ other3 13(6.4 %)
+mitral 10 (5.0 %)
+ other4 8 (4.0 %)
+ tricuspid 1 (0.5 %)
Tricuspid + mitral + aortic + other5 6 (3.0 %)
CABG
+ aortic 40 (19.8 %)
+ other6 21 (10.4 %)
+mitral 13 (6.4 %)
+ other7 14 (6.9 %)




+mitral + tricuspid 2 (1.0 %)
+ other9 12 (5.9 %)
+ aortic + mitral + tricuspid + other10 9 (4.5 %)
Isolated 7 (3.6 %)
CABG coronary artery bypass graft
a“Other” surgical procedures include, but are not limited to: maze procedure
(uni/biatrial)1,2,4–10, atrial reduction1,2,4–10, debridement of posterior mitral
annular calcification2,7–10, intra-aortic balloon pump placement4,5,6,8,9, and
patent foramen ovale closure1,3,9
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Females were 2.44 times more likely to die than males.
None of the independent variables were statistically sig-
nificant predictors of 30-day complications.
Cox proportional hazards analysis was also performed
using mid-term mortality for patients who survived at
least 30 days following the surgery as the dependent
variable. Significant predictors of mortality included fe-
male gender, age, and ventilation > 48 h (Table 7).
A Kaplan-Meier survival curve is shown in Fig. 1 for
patients who survived at least 30 days following surgeries
with cross clamp times greater than 300 min. One, three,
five, and seven year survival was 91.9 %, 83.2 %, 75.6 %,
and 65.7 % respectively.
Discussion
Complex surgical procedures requiring long cross clamp
times for complete repair are often patients’ only chance
for survival and better quality of life. Decisions about
operability are often difficult, as research has shown that
XCL time is an independent predictor of mortality and
morbidity in patients undergoing cardiac surgeries [1, 2,
4]. Our results demonstrate that while high in relation
to less complex surgeries, a 12.4 % mortality in these
complex, high risk patients is lower than that reported
by studies in the literature addressing longer XCL times.
Nissinen et al. observed a 31.5 % 30-day mortality rate
Table 3 Intraoperative characteristics, 30-day postoperative
outcomes, and their distributions among the patients (n = 202)
Variable No. (%)
Intraoperative
Procedure (% CABG) 156 (77.2 %)
IABP 12 (5.9 %)
CPB time (min)a 421 ± 70
XCL time (min)a 346 ± 45
IMA used
Left or Right IMA 115/157 (73.2 %)
Both IMAs 1/157 (0.6 %)
Postoperative






≤ 48 h 148 (73.3 %)
> 48 h 54 (26.7 %)
Postoperative ventilation (h)b 13.0 (6.0–66.9)
Deep sternal infection 3 (1.5 %)
Stroke 8 (4.0 %)
Atrial fibrillation 53 (26.2 %)
Pneumonia 17 (8.4 %)
Renal failure 21 (10.4 %)
Bleeding requiring reoperation 13 (6.4 %)
Intensive care unit readmission 8 (4.0 %)
Total intensive care unit stay (h) b 96.0 (43.0–212.3)
Total hospital stay (days) b 11.0 (7.0–20.5)
IABP intra-aortic balloon pump, CPB cardiopulmonary bypass, XCL cross-clamp
time, IMA inferior mesenteric artery
aMean ± SD
#Median (interquartile range)
Table 4 Univariate analysis of pre-, intra-, and postoperative












Erab 0.162 0.024 0.393
Preoperative
Gender 0.001 0.066 0.009
Statusc 0.186 0.691 0.157
Left main discharge >50 0.071 0.313 0.183
Patient Age 0.015 0.066 0.322
Angina 0.137 0.0497 0.699
Diabetes 0.375 0.750 0.378
Smoker 0.898 0.344 0.161
First operation vs. reoperation 0.521 0.478 >0.999
NYHA score 0.078 0.248 0.210
Intraoperative
Surgery typed 0.890 0.283 0.240
Perioperative MI 0.130 0.232 0.413
Perfusion time <0.001 0.018 0.045
Cross clamp time 0.002 0.006 0.509
Postoperative
Deep sternal infection - >0.999 -
Stroke - 0.392 -
Bleeding requiring reoperation - >0.999 -
Atrial fibrillation - >0.999 -
Pneumonia - >0.999 -
Ventilation >48 h - 0.002 -
Renal failure - 0.587 -
Ventilation time - 0.026 -
Total ICU stay - 0.002 -
Length of hospital stay - 0.001 -
ICU readmission - >0.999 -
NYHA New York Heart Association, MI myocardial infarction, ICU intensive
care unit
aAll mid-term deaths were more than 30 days following the operation
bSurgeries from 2001–2006 were compared to those from 2007–2012; the
former time period was the reference category emergent vs.
elective procedures
cEmergent vs. elective procedures
dSurgeries including coronary artery bypass grafts (CABGs) were compared to
those that did not
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in their patients with XCL times greater than 240 min
[2]. Furthermore, Al-Sarraf et al. found that high risk
patients (EuroScore ≥ 6) with XCL times >90 min and
those with XCL times < 60 min and ≤ 90 min were re-
spectively 4.7 and 3.1 times more likely to die than those
with XCL times ≤ 60 min [1]. Doenst et al. found that
XCL times greater than 30 min were associated with a
steadily increasing rate of mortality [4].
Our results differ slightly from the above findings. In our
cohort, perfusion time was significantly associated with all
deaths, mid-term deaths and operative deaths by univariate
analysis, while XCL time was associated with all deaths and
mid-term deaths only. Both perfusion time and XCL time
were significantly associated with 30-day complications by
univariate analysis. Neither perfusion time nor XCL time
was significantly associated with mortality or complications
by multivariate analysis, although XCL time was associated
with mid-term mortality with p = 0.081 under Cox propor-
tional hazards analysis. Studies have shown that modern
methods of myocardial protection have greatly reduced the
mortality expected from long XCL times. Bezon et al.
showed an absence of increased mortality and morbidity
during prolonged cross-clamping with continuous retro-
grade tepid cardioplegia with systemic normothermia [7].
Furthermore, Bar-el et al. found no increase in mortality in
operations requiring more than two hours of cross-clamp
time with the use of antegrade administration of warm, un-
diluted blood and continuous retrograde infusion of tepid,
undiluted blood with added potassium and magnesium
[10]. Myocardial protection is extremely important and a
standardized approach was utilized with cardioplegia deliv-
ered every 15 min during cross-clamping. Septal tempera-
tures were monitored and kept under 10° Celsius. Right
ventricular protection via grafts to the right side and inte-
grated into the cardioplegia circuit is used if there is disease.
Antegrade cardioplegia in the root or ostial right perfusion
is used if there is no disease, with the addition of ice on the
right ventricle surface.
CPB duration has been shown to be positively correlated
with interleukin-6 response that is responsible for the sys-
temic inflammatory response (SIR) associated with adverse
outcomes in cardiac surgery [8]. SIR is multifactorial in
cause, but evidence suggests that blood-to-artificial surface
contact leads to platelet activation and results in an altered
platelet shape. This altered shape activates cascades produ-
cing coagulants, complement and inflammatory cytokines
like IL-6 [8]. Furthermore, studies such as that by Wan et
al. showed increasing levels of Il-6, Il-8, and Il-10 with lon-
ger ischemic times [13]. Thus with extremely long cross
clamp times there is a possibility of increased inflammatory
mediators which can lead to increased incidence of compli-
cations through the SIR. Heparin coated circuits and the
Table 5 Univariate analysis of pre-, intra-, and postoperative















Cross clamp time 0.040
Postoperative
Length of hospital stay <0.001
Total ICU stay <0.001
Ventilation >48 h <0.001
NYHA New York Heart Association, ICU intensive care unit
Table 6 Logistic regression analysis of independent variables with respect to 30-day mortality and complicationsa
30-day Mortality 30-day Complications
Variable OR (95 % CI) p-value OR (95 % CI) p-value
Patient age 1.02 (0.98–1.07) 0.305 1.00 (0.97–1.03) 0.902
Genderb 2.44 (1.004–5.93) 0.049 1.19 (0.62–2.31) 0.599
Perfusion time 1.01 (1.00–1.01) 0.113 1.01 (1.00–1.01) 0.139
Cross clamp time 0.99 (0.98–1.01) 0.362 1.00 (0.99–1.01) 0.968
Surgery typec 0.64 (0.24–1.71) 0.377 0.53 (0.25–1.12) 0.097
Erad 1.17 (0.48–2.83) 0.725 0.90 (0.50–1.63) 0.726
ICU intensive care unit
aAll mortalities for this analysis occurred perioperatively
bThe reference category was males
cSurgeries including coronary artery bypass grafts (CABGs) were compared to those that did not; the reference category was surgeries involving CABG
dSurgeries from 2001–2006 were compared to those from 2007–2012; the former time period was the reference category
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avoidance of cardiotomy suction has been used as a possible
means to decrease inflammatory mediators and thus SIR.
A number of studies have reported the correlation
between prolonged XCL and bypass time and renal com-
promise [1, 3, 6, 11]. This acute kidney injury is multifac-
torial and related to preoperative renal function as well as
intraoperative factors such as hypoperfusion, emboli, and
medications. Taniguchi et al. showed that when CPB times
exceed 90 min, the chance of renal dysfunction, an inde-
pendent risk factor for mortality, increased significantly
[14]. In 2003 Boldt et al. measured urinary proteins ex-
creted and found that with bypass times greater than
90 min these markers of renal injury were elevated and
remained so compared to those without these times [15].
In our cohort, renal failure was classified as an increase in
creatinine of 3.0 times over baseline or as any patients
requiring dialysis. While renal failure was not significantly
associated with mortality by univariate analysis, a rela-
tively large number (10.4 %) of patients experienced renal
failure. A review by Rosner and Okuza showed that mor-
tality in patients requiring dialysis after cardiac surgery
was uniformly high in fifteen studies, at an average of 60–
70 % [24]. Therefore, optimization of preoperative renal
function by delaying surgery until all effects from dye ad-
ministration are gone, discontinuing nephrotoxic medica-
tions and renal consultation in these patients is crucial.
Intraoperative management by avoiding hypotension and
severe hemodilution can be utilized to mediate renal com-
plications [16].
Prolonged postoperative ventilation (>48 h) was signifi-
cantly associated with both 30-day and mid-term mortality
in our cohort under univariate analysis. A high incidence of
pneumonia, prolonged ventilation and other pulmonary
complications have been shown in prior literature [1, 3, 12].
For example, Al-Sarraf et al. showed that XCL times greater
than or equal to 90 min put a patient at 1.6 times the risk
of pulmonary complications compared to patients with a
shorter ischemic time [1]. One study suggests that this is
likely a result of increased vascular resistance in the lungs,
and the accumulation of anaerobic metabolic byproducts in
blood flowing through the pulmonary circuit following
declamping in addition to a postoperative increase in mem-
brane permeability with subsequent pulmonary edema
causing further complications [9]. It has been suggested
that the decrease in arterial oxygen tension and other
pulmonary imbalances due to heparin use are caused by
perioperative pulmonary microemboli [17]. Leukocyte de-
pletion filters and a reduced use of the cardiotomy suction
device can both be utilized to reduce postoperative pul-
monary complications [18].
A high incidence of stroke has been shown to occur with
prolonged XCL [1]. A 2000 study demonstrated that longer
durations of bypass were associated with increased embolic
load on the brain [19]. A moderate incidence of stroke was
observed in this study (4.0 %), although this is consistent
with other studies in the literature [1, 5]. Although the cor-
relation between the incidence of stroke and mortality did
not reach statistical significance in our study, of the 4.0 %
who suffered a stroke, 75 % (6/8) died within thirty days of
the procedure, as compared to 12.4 % of the entire cohort.
A cohort with a higher number of patients may demonstrate
a statistically significant relationship with the incidence of
postoperative stroke and mortality. Although previous re-
search has reported a high incidence of complications such
as renal failure and stroke with prolonged XCL, the correla-
tions between these complications and XCL time in these
studies was not assessed [1, 5, 11]. In the past ten years, rou-
tine preoperative CT scanning of the thoracic aorta as well
as intraoperative epiaortic echocardiography and cerebral
oximetry have been utilized to attempt to reduce the inci-
dence of stroke.
Table 7 Cox proportional hazards regression analysis of
independent variables with respect to the mid-term mortalitya
Variable OR (95 % CI) p-value
Genderb 2.11 (1.13–3.94) 0.020
Perfusion time 1.00 (0.99–1.01) 0.933
Cross clamp time 1.01 (0.999–1.02) 0.081
Surgery typec 1.44 (0.65–3.22) 0.372
Erad 1.06 (0.53–2.13) 0.861
Age 1.04 (1.004–1.07) 0.027
Ventilation > 48 h 2.72 (1.46–5.08) 0.002
aAll mortalities occurred more than 30 days after the surgical procedure
bThe reference category was males
cSurgeries including coronary artery bypass grafts (CABGs) were compared to
those that did not; the reference category was surgeries involving CABG
dSurgeries from 2001–2006 were compared to those from 2007–2012; the
former time period was the reference category
Fig. 1 Kaplan-Meier survival curve predicting survival of patients
Shultz et al. Journal of Cardiothoracic Surgery  (2016) 11:105 Page 6 of 8
Multiple studies have suggested that female gender is
associated with increased mortality and morbidity [20–22].
In our cohort, female gender was significantly correlated
with mid-term mortality by Cox proportional hazards ana-
lysis, and was significantly associated with 30-day mortality
by logistic regression. Our results also demonstrated a 2.44
times higher 30-day mortality and a 2.11 times higher mid-
term mortality in females who underwent operations
requiring prolonged cross clamp times. Blankenstein et al.
demonstrated double the operative mortality in women
who underwent CABG surgery [20]. Abramov et al. also
showed an increase in early mortality in women (2.7 %) vs.
men (1.8 %) after CABG surgery [21]. There are many
possible explanations for this increased operative mortality.
Abramov et al. suggest that women have significantly
increased incidences of preoperative risk factors such as
diabetes, hypertension, peripheral vascular disease, congest-
ive heart failure, urgent operation and angina class 3 or 4
relative to men [21]. Similarly, Tran et al. suggest that
women have more complex morphology due to under-
diagnosis of valve disease, and a general underestimation of
the severity of cardiac illness in females [22]. Finally, Blan-
kenstein et al. suggest that the lower BSA of females relative
to males acts as a surrogate for smaller coronary vessel size,
which may lead to reduced graft patency and negatively in-
fluence mid-term survival. The same study found that
when mortality is risk adjusted for this higher prevalence of
preoperative complications and lower BSA, females still
have 22 % higher operative mortality than males [20].
Despite the above risk factors and postoperative compli-
cations, patients who survived thirty days postoperatively
and were discharged from the hospital had excellent mid-
term survival. One, three, five and seven year survival in
our cohort was 91.9 %, 83.2 %, 75.6 % and 65.7 % respect-
ively. The era in which the surgery took place was not
significantly associated with complications or mortality by
multivariate analysis.
These data demonstrate that the prognoses for complex
surgeries with extended XCL times are reasonable and that
it may be reasonable to offer surgery to very complex pa-
tients who may have been refused in the past. Optimization
of patients prior to undergoing these complex procedures
is vital for improving outcomes. Waiting 5–7 days after a
catheterization or CT angiogram minimizes any potential
of nephrotoxicity in elective cases. Holding anticoagulants
can minimize the deleterious effect of blood transfusions,
and maximizing cardiac medications such as beta-blockers
and blood pressure medication may benefit patients. Sur-
geries involving patients with high HgA1c levels should be
delayed until said levels are controlled. Finally, from a life-
style perspective, insisting that patients stop smoking and
requiring patients to be ambulatory as soon as possible
(with the goal of achieving twenty minutes of continuous
activity) may also enhance beneficial outcomes.
Limitations to this study include it being a retrospective
review of prospective data. For mid-term data, only sur-
vival was monitored and we were not able to assess quality
of life. There is also no ability to assess why cross clamp
time was so long as operative notes were absent or incom-
plete and we were unable to discern all problems encoun-
tered, however we excluded patients who needed to have
the cross clamp applied a second time to attempt to
minimize this. Another possible limitation to this study is
the small sample size (n = 202). Finally, the study is limited
in its design as a single institution study over a long period
of time. However, after stratifying patients by time, we
found that era is not a statistically significant predictor of
mortality or postoperative complications.
Conclusion
In conclusion, there is significant but acceptable short-
term mortality and morbidity in this cohort of complex
patients. There is also excellent mid-term survival in pa-
tients who survive the initial operation. Female gender was
significantly associated with both 30-day mortality and
mid-term mortality by multivariate analysis. Patient age
and prolonged postoperative ventilation were significantly
associated with mid-term mortality by cox proportional
hazards analysis. There are few studies that look at mid-
term survival in patients undergoing these surgeries, and
our findings demonstrate a need for further longitudinal
studies in these patients. Future studies should focus on
preoperative optimization of these patients in terms of
respiratory function and renal function. Postoperative care
also needs to be studied and optimized, which we believe
incorporates a multidisciplinary team approach to these
complex patients.
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